Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
The Treatment Details presented here guide international patients through every stage of ovarian cancer care at Liv Hospital. Ovarian cancer affects roughly 1 in 78 women worldwide, and early, coordinated treatment dramatically improves outcomes. This page explains surgical options, chemotherapy regimens, emerging targeted therapies, and the supportive services that make a seamless experience possible for patients traveling to Istanbul. Whether you are newly diagnosed or seeking a second opinion, you will find clear information on the multidisciplinary approach that Liv Hospital employs, along with practical guidance on logistics, interpreter assistance, and post‑treatment follow‑up.
Our experts combine state‑of‑the‑art technology with personalized medicine to create a treatment plan tailored to each individual’s disease profile and personal circumstances. Below you will find detailed sections covering every major component of ovarian cancer management, presented in an accessible format for patients and families from around the globe.
Liv Hospital follows internationally recognized guidelines to offer a full spectrum of ovarian cancer therapies. Treatment plans are designed after a thorough multidisciplinary review that includes gynecologic oncologists, medical oncologists, radiologists, and supportive care specialists. The main modalities include:
Choosing the right combination depends on tumor stage, genetic mutations (such as BRCA1/2), patient age, and overall health. Below is a concise comparison of the primary treatment pathways:
Understanding these treatment details helps patients make informed decisions and set realistic expectations for recovery and long‑term health.
Surgery remains the cornerstone of curative intent for ovarian cancer. At Liv Hospital, two principal surgical strategies are employed, each tailored to the disease burden and patient condition.
This procedure aims to remove as much visible tumor as possible (optimal debulking). It often involves:
Minimally invasive laparoscopy may be used for early‑stage disease, while advanced cases typically require an open laparotomy. The surgical team employs advanced imaging and intra‑operative navigation to achieve maximal tumor clearance.
When tumors are extensive or the patient’s performance status is compromised, chemotherapy is given first to shrink disease, making subsequent surgery safer and more effective. The interval surgery follows the same principles of debulking but usually involves less extensive dissection.
Post‑operative care includes:
Our surgeons provide detailed pre‑operative counseling, including expected hospital stay (typically 4‑7 days) and recovery timelines, ensuring patients feel prepared for each step of the journey.
Systemic chemotherapy is administered to eradicate microscopic disease and reduce recurrence risk. Liv Hospital follows evidence‑based regimens while customizing doses based on genetic testing, renal function, and tolerability.
The most common first‑line protocol combines a platinum compound (carboplatin) with a taxane (paclitaxel). Typical administration:
Patients receive anti‑emetic prophylaxis and growth‑factor support as needed. Side‑effect management includes neuropathy monitoring, blood count checks, and renal function assessment.
Genetic profiling (e.g., BRCA mutation status) influences regimen selection. For BRCA‑mutated tumors, adding a PARP inhibitor as maintenance therapy after chemotherapy has shown significant survival benefits. Dose reductions or alternative agents (such as liposomal doxorubicin) are considered for patients with comorbidities.
Our oncology nurses provide education on self‑care, nutrition, and symptom reporting, empowering patients to actively participate in their treatment course.
Beyond conventional chemotherapy, Liv Hospital offers cutting‑edge targeted agents and immunotherapy options, often within clinical trials. These therapies focus on molecular pathways that drive tumor growth.
Poly (ADP‑ribose) polymerase (PARP) inhibitors such as olaparib, niraparib, and rucaparib are approved for maintenance therapy in patients with homologous recombination deficiency (HRD). Benefits include:
Common side effects include fatigue, nausea, and mild hematologic changes, which are monitored through regular blood tests.
Bevacizumab, an antibody that blocks vascular endothelial growth factor (VEGF), can be combined with chemotherapy or used as maintenance. It reduces tumor blood supply, slowing growth.
Immune checkpoint inhibitors (e.g., pembrolizumab) are being investigated for ovarian cancer, especially in tumors expressing high microsatellite instability (MSI‑H). Liv Hospital’s research department offers enrollment in Phase I/II trials, providing patients access to novel agents under rigorous safety oversight.
Comprehensive cancer care extends beyond tumor‑directed therapy. Liv Hospital integrates supportive services to address physical, emotional, and nutritional needs throughout the treatment journey.
Registered dietitians develop individualized meal plans to maintain weight, support immune function, and mitigate treatment‑related taste changes. Supplements are prescribed when deficiencies are identified.
Early mobilization reduces postoperative complications. Certified physiotherapists guide patients through core strengthening, breathing exercises, and gradual return to daily activities. For those at risk of lower‑extremity lymphedema, compression therapy and specialized massage are offered.
Licensed psychologists provide counseling for anxiety, depression, and coping strategies. Support groups—conducted in multiple languages—allow patients and families to share experiences and build a community.
Liv Hospital’s 360‑degree international patient service ensures that every aspect of your journey—from the moment you contact us until long‑term follow‑up—is managed with precision.
All logistical details are handled by a single point of contact, allowing patients to focus on recovery while the Liv Hospital team takes care of the rest.
Liv Hospital is a JCI‑accredited, internationally recognized center that combines cutting‑edge oncology expertise with a patient‑centric approach. Our multidisciplinary teams use the latest evidence‑based protocols, advanced robotic surgery, and personalized medicine to deliver optimal outcomes. For international patients, we provide seamless coordination—from visa assistance to multilingual interpreter services—ensuring a comfortable and stress‑free experience throughout treatment.
Ready to discuss your personalized ovarian cancer treatment plan? Contact Liv Hospital’s international patient office today to schedule a confidential consultation and start your journey toward recovery.
Send us all your questions or requests, and our expert team will assist you.
Patients receive a multidisciplinary evaluation that leads to a personalized plan. The core options include primary or interval cytoreductive surgery to remove visible tumor, systemic platinum‑based chemotherapy (carboplatin plus paclitaxel), targeted agents like PARP inhibitors for BRCA‑mutated disease, anti‑angiogenic drugs such as bevacizumab, and, when appropriate, immunotherapy within clinical trials. Maintenance therapy may follow initial treatment to prolong progression‑free survival. Each modality is selected based on stage, genetics, age, and overall health.
International patients benefit from a single point of contact who arranges consultation dates that fit travel plans, assists with medical‑visa paperwork, and organizes airport transfers. Professional interpreters fluent in multiple languages are available in‑person and virtually. The hospital partners with nearby hotels and serviced apartments to provide discounted stays. After discharge, patients can continue follow‑up via tele‑medicine and access electronic medical records, ensuring continuity of care once they return home.
Primary cytoreductive surgery aims for optimal debulking by removing the uterus, ovaries, omentum, affected peritoneal surfaces, and sampling lymph nodes. It may be performed via minimally invasive laparoscopy for early‑stage disease or open laparotomy for advanced cases. When tumor burden is high or the patient’s condition is fragile, neoadjuvant platinum‑based chemotherapy is given first to shrink tumors, after which interval surgery is performed with less extensive dissection. Both approaches are supported by enhanced recovery protocols, early mobilization, and intensive postoperative monitoring.
For patients with homologous recombination deficiency or BRCA mutations, PARP inhibitors (olaparib, niraparib, rucaparib) are used as maintenance therapy after response to chemotherapy, extending progression‑free survival. Bevacizumab, an anti‑VEGF antibody, can be combined with chemotherapy or given as maintenance to inhibit tumor blood vessel growth. Liv Hospital also enrolls eligible patients in clinical trials evaluating immune checkpoint inhibitors such as pembrolizumab, especially for tumors with high microsatellite instability. All targeted agents are monitored closely for specific side effects like hypertension for bevacizumab or hematologic changes for PARP inhibitors.
Liv Hospital’s supportive care team addresses physical and emotional needs. Multimodal analgesia—including opioids, NSAIDs, and nerve blocks—controls pain, while anti‑nausea regimens are tailored to each chemotherapy protocol. Registered dietitians create individualized meal plans to maintain weight and support immunity, and supplements are added when deficiencies arise. Certified physiotherapists guide early mobilization, core strengthening, and breathing exercises, and provide compression therapy for lymphedema risk. Licensed psychologists offer counseling for anxiety, depression, and coping strategies, and multilingual support groups foster community among patients and families.
BlogCancerFeb 19, 2026Many people are surprised to learn that lower back pain can signal ovarian cancer. This is true if the pain...
BlogCancerFeb 19, 2026Abdominal bloating and a visibly larger stomach are common signs of ovarian cancer. These symptoms are ofte...
BlogCancerFeb 19, 2026Many people think that ovarian cancer always leads to vaginal bleeding. But, the truth is more nuanced. We&...
BlogCancerFeb 19, 2026Many women feel like they need to go to the bathroom all the time. But, it’s often because of ovarian...
BlogCancerFeb 19, 2026Ovarian cancer is often called a ‘silent killer’ because its symptoms are not obvious and it...
BlogCancerFeb 19, 2026Ovarian cancer is a major threat to women’s health. Some groups face much higher risks because of the...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
